“Moderately Hypofractionated” Radiotherapy with a Simultaneously Integrated Boost for Synchronous Treatment of Prostate and Anorectal Cancer
Elizabeth Sutton(Mayo Clinic in Arizona), Krishan R. Jethwa(Mayo Clinic), James L. Leenstra(WinnMed), Daniel K. Ebner(National Institutes for Quantum Science and Technology), Christopher L. Hallemeier(Mayo Clinic in Arizona), W.W. Wong(Mayo Clinic Hospital), Abigail L. Stockham(Mayo Clinic in Arizona), Kenneth W. Merrell(Mayo Clinic), C. Doodoo(Mayo Clinic Hospital), Michael G. Haddock(Mayo Clinic in Arizona), A. Amundson(Mayo Clinic in Arizona)
International Journal of Radiation Oncology*Biology*Physics
September 29, 2023
Cited by 0
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)
|Journal of Clinical Oncology|2008|270
Oesophageal cancer
|The Lancet|2024|265